Eli Lilly and Co (LLY)
818.93
-10.81
(-1.30%)
USD |
NYSE |
Nov 01, 16:00
816.48
-2.45
(-0.30%)
After-Hours: 20:00
Eli Lilly Debt to Equity Ratio: 2.185 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.185 |
| June 30, 2024 | 2.130 |
| March 31, 2024 | 2.046 |
| December 31, 2023 | 2.342 |
| September 30, 2023 | 1.798 |
| June 30, 2023 | 1.701 |
| March 31, 2023 | 1.688 |
| December 31, 2022 | 1.525 |
| September 30, 2022 | 1.578 |
| June 30, 2022 | 1.968 |
| March 31, 2022 | 1.769 |
| December 31, 2021 | 1.880 |
| September 30, 2021 | 2.203 |
| June 30, 2021 | 2.563 |
| March 31, 2021 | 2.349 |
| December 31, 2020 | 2.942 |
| September 30, 2020 | 3.506 |
| June 30, 2020 | 3.989 |
| March 31, 2020 | 5.596 |
| December 31, 2019 | 5.876 |
| September 30, 2019 | 4.501 |
| June 30, 2019 | 5.678 |
| March 31, 2019 | 6.437 |
| December 31, 2018 | 1.048 |
| September 30, 2018 | 0.9694 |
| Date | Value |
|---|---|
| June 30, 2018 | 1.058 |
| March 31, 2018 | 0.8052 |
| December 31, 2017 | 1.177 |
| September 30, 2017 | 0.9043 |
| June 30, 2017 | 0.8731 |
| March 31, 2017 | 0.7303 |
| December 31, 2016 | 0.7357 |
| September 30, 2016 | 0.5997 |
| June 30, 2016 | 0.6375 |
| March 31, 2016 | 0.5414 |
| December 31, 2015 | 0.5475 |
| September 30, 2015 | 0.5308 |
| June 30, 2015 | 0.5453 |
| March 31, 2015 | 0.551 |
| December 31, 2014 | 0.5218 |
| September 30, 2014 | 0.3173 |
| June 30, 2014 | 0.2953 |
| March 31, 2014 | 0.2871 |
| December 31, 2013 | 0.2957 |
| September 30, 2013 | 0.3128 |
| June 30, 2013 | 0.349 |
| March 31, 2013 | 0.3652 |
| December 31, 2012 | 0.3746 |
| September 30, 2012 | 0.3436 |
| June 30, 2012 | 0.385 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
1.525
Minimum
Dec 2022
5.876
Maximum
Dec 2019
2.582
Average
2.158
Median
Debt to Equity Ratio Benchmarks
| Amgen Inc | 8.024 |
| Johnson & Johnson | 0.5096 |
| Merck & Co Inc | 0.8671 |
| Viking Therapeutics Inc | -- |
| Moderna Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 75.61B |
| Total Liabilities (Quarterly) | 61.29B |
| Shareholders Equity (Quarterly) | 14.24B |
| Current Ratio | 1.273 |
| Net Debt Paydown Yield | -0.31% |